Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1

Annals of Surgery

Volumn 257, Issue 2, 2013, Pages 308-314

  Lopez, Caroline L ^a   Falconi, Massimo ^b   Waldmann, Jens ^a   Boninsegna, Letizia ^b,c   Fendrich, Volker ^a   Goretzki, Peter K ^d   Langer, Peter ^a   Kann, Peter H ^a   Partelli, Stefano ^b,c   Bartsch, Detlef K ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF VERONA   (Italy)

^c SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^d Lukaskrankenhaus GmbH   (Germany)

Author keywords

gastrinoma; MEN1; pancreaticoduodenectomy; surgery; ZES

Indexed keywords

ABDOMINAL ABSCESS; ACUTE PANCREATITIS; ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; DISTANT METASTASIS; DUODENUM CARCINOMA; FEMALE; FOLLOW UP; GASTRINOMA; HOSPITAL DISCHARGE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIVER METASTASIS; LYMPH NODE DISSECTION; MALE; MORBIDITY; MULTICENTER STUDY; MULTIPLE ENDOCRINE NEOPLASIA; OUTCOME ASSESSMENT; PANCREAS CARCINOMA; PANCREAS FISTULA; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REOPERATION; SURGICAL MORTALITY; TUMOR RECURRENCE;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; DUODENAL NEOPLASMS; FEMALE; GASTRINOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATICODUODENECTOMY; YOUNG ADULT;

EID: 84872298508     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182536339     Document Type: Article

References (41)

1. Chandrasekharappa SC, Guru SC, Manickham P, et al. Positional cloning of the gene for multiple endocrine neoplasia type 1. Science. 1997;276:404-407.
2. Agarwal SK, Kester MB, Debelenko LV, et al. Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states. Hum Mol Genet. 1997;6:1169-1175.
3. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med. 1954;16:363-371.
4. Doherty GM, Olson JA, Frisella MM, et al. Lethality of multiple endocrine neoplasia type I. World J Surg. 1998;22:581-587.
5. Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469-1492.
6. Carty SE, Helm AK, Amico JA, et al. The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1. Surgery. 1998;124:1106-1111.
7. Goudet P, Murat A, Binquet C, et al. Risk factors and causes of death in MEN1 disease. AGTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients. World J Surg. 2010;34:249-255.
8. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990;15:322;723-727.
9. Anlauf M, Perren A, Meyer CL, et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterol-ogy. 2005;128:1187-1198.
10. Jensen RT, Berna MJ, Bingham DB, et al. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies. Cancer. 2008;1:113;1807-1843.
11. Weber HC, Venzon DJ, Lin JT, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995;108:1637-1649.
12. Gibril F, Venzon DJ, Ojeaburu JV, et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab. 2001;86:5282-5293.
13. Yu F, Venzon DJ, Serrano J, et al. Prospective study of the clinical course, prognostic factors, causes of death, and survival in patients with long-standing Zollinger-Ellison syndrome. J Clin Oncol. 1999;17:615-630.
14. Fendrich V, Langer P, Celik I, et al. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors. Ann Surg. 2006;244:845-851.
15. Tonelli F, Fratini G, Nesi G, et al. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg. 2006;244:61-70.
16. Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg. 2001;234:495-505.
17. Norton JA, Jensen RT. Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome. Ann Surg. 2004;240:757-773.
18. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery. 2000;128:958-966.
19. Bartsch DK, Fendrich V, Langer P, et al. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2005;242:757-764.
20. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med. 1998;243:495-500.
21. Gauger PG, Doherty GM, Broome JT, et al. Completion pancreatectomy and duodenectomy for recurrent MEN-1 pancreaticoduodenal endocrine neoplasms. Surgery. 2009;146:801-806.
22. Akerström G, Hessman O, Skogseid B, et al. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN1. Langenbecks Arch Surg. 2002;386:558-569.
23. Norton JA, Fraker DL, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med. 1999;341:635-644.
24. Imamura M, Komoto K, Ota S, et al. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients. World J Gastroenterol. 2011;17:1343-1353.
25. Mignon M, Cadiot G. Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med. 1998;243:489-494. Review.
26. Imamura M, Takahashi K. Use of selective secretin injection test to guide surgery in patients with Zollinger-Ellison Syndrome. World J Surg. 1993;17:433-438.
27. Lopez CL, Waldmann J, Fendrich V, et al. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1. Langenbecks Arch Surg. 2011;396:1187-1196.
28. Bosman F, Carneiro F, Hruban R, et al. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010.
29. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205-213.
30. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. International Study Group on Pancreatic Fistula Definition. Surgery. 2005;138:8-13.
31. Tonelli F, Giudici F, Fratini F, et al. Pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: review of literature. Endocr Pract. 2011;6:1-23.
32. Donow C, Pipeleers-Marichal M, Schröder S, et al. Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1 and malignancy. Cancer. 1991;68:1329-1334.
33. Pipeleers-Marichal M, Donow C, Heitz PU, et al. Pathologic aspects of gastrinomas in patients with Zollinger-Ellison syndrome with and without multiple endocrine neoplasia type 1. World J Surg. 1993;17:481-488.
34. Fitzmaurice C, Seiler CM, Büchler MW. et al. Survival, mortality and quality of life after pylorus-preserving or classical Whipple operation. A systematic review with meta-analysis. Chirurg. 2010;81:454-471.
35. Moldovanu R, Grecu F, Târcoveanu E, et al. Pancreaticoduodenectomy with or without pylorus preservation: a retrospective analysis of 137 patients. Chirurgia (Bucur). 2007;102:651-664.
36. Lairmore TC, Chen VY, De Benedetti MK, et al. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2000;231:909-918.
37. Waldmann J, Fendrich V, Habbe N, et al. Screening of patients with endocrine neoplasia type 1 (MEN-1): a critical analysis of its value. Wo r l d J Surg. 2009;33:1208-1218.
38. Proye CAG, Lokey JS. Current concepts in functioning endocrine tumors of the pancreas. World J. Surg. 2004;28:1231-1238.
39. Proye C, Malvaux P, Pattou F, et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery. 1998;124:1134-1143; discussion 1143-1144.
40. Ruszniewski P, Amouyal P, Amouyal G, et al. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery. 1995;117:629-635.
41. Stadil F, Bardram L, Gustafsen J, et al. Surgical treatment of the Zollinger-Ellison syndrome. World J Surg. 1993;17:463-467.